Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Details) - Schedule of diluted net loss per share

v3.20.2
Net Loss Per Share (Details) - Schedule of diluted net loss per share - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 888,865 1,500,511 888,865 1,500,511
Stock options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 178,304 188,595 178,304 188,595
Warrants [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Total common stock equivalents 710,561 1,311,916 710,561 1,311,916